DSD-C192

Non-DSD: congenital adrenal hyperplasia (11β-hydroxylase deficiency, CAH) — endocrine disorder, 46,XY male with normal phenotype · 46,XY · DSD-C192

DSD-C192 · Non-DSD · 2025

Genes CYP11B1 · Karyotype 46,XY · Phenotypes HPO:0004322, Short stature (HP:0004322)

Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency (CYP11B1 homozygous c.1231G>C) with bilateral testicular adrenal rest tumors (TARTs) — this 46,XY male had normal sex development and is not a disorder of sex development.

Images · 3

Case fields and evidence

Category

Non-DSD: congenital adrenal hyperplasia (11β-hydroxylase deficiency, CAH) — endocrine disorder, 46,XY male with normal phenotype

Age

22 years 10 months (onset at age 3)

Sex

Male (raised male, 46,XY)

Karyotype

46,XY

Genetics

CYP11B1

Phenotypes

Short stature (HP:0004322)

Diagnosis

Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency (CYP11B1 homozygous c.1231G>C) with bilateral testicular adrenal rest tumors (TARTs) — this 46,XY male had normal sex development and is not a disorder of sex development.

Follow-up

Since Oct 2024: May 2025 BP 120/80, testes reduced, K 4.0; Sep 2025 BP 130/90, testes further reduced, A:T 0.34, continued steroids.

General phenotype

Male phenotype, precocious puberty, short stature, generalized hyperpigmentation (skin/lips/palms), bilateral firm nodular enlarged testes, hypertension.

Imaging

Bulky adrenals (US); bilateral intratesticular hypoechoic vascular lesions (TARTs) 33.1 cc right, 46.2 cc left; wrist X-ray advanced bone age; posterior subcapsular cataract, grade-2 hypertensive retinopathy.

Laboratory findings

Low cortisol (0.52–3.21 µg/dL), high ACTH (1261 pg/mL); 17-OHP elevated (11.7 ng/mL); 11-deoxycortisol 11000 ng/dL (markedly high); DOC 3.4 µg/dL; androstenedione 36600 ng/L; A:T 5.11; testosterone 6.5–7.15 ng/mL; Na normal, K low (2.8); suppressed FSH/LH.

Management

Hydrocortisone + dexamethasone (night) + spironolactone + amlodipine; previously GnRH analog (leuprolide) for central precocious puberty; after 3-yr discontinuation and relapse, restarted steroids with reduced testicular size and improved BP.

Pathology

Not reported (TARTs imaging-based, no biopsy)

Genetic variants

c.1231G>C, p.Gly411Arg

Clinical history

See source

Perinatal history

See source

Family history

See source

Growth and development

See source

External genital examination

See source

Puberty / Tanner

See source

Cite this resource

DSD Research Library | Non-DSD: congenital adrenal hyperplasia (11β-hydroxylase deficiency, CAH) — endocrine disorder, 46,XY male with normal phenotype · 46,XY · DSD-C192 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-C192?version=v1.4.0